Assessing the Public Health Risk of Shiga Toxin-Producing Escherichia coli by Use of a Rapid Diagnostic Screening Algorithm

被引:31
作者
de Boer, Richard F. [1 ,2 ]
Ferdous, Mithila [3 ]
Ott, Alewijn [2 ,3 ]
Scheper, Henk R. [2 ]
Wisselink, Guido J. [1 ]
Heck, Max E. [4 ]
Rossen, John W. [3 ]
Kooistra-Smid, Anna M. D. [1 ,2 ,3 ]
机构
[1] Certe Lab Infect Dis, Dept Res & Dev, Groningen, Netherlands
[2] Certe Lab Infect Dis, Dept Med Microbiol, Groningen, Netherlands
[3] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands
[4] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands
关键词
HEMOLYTIC-UREMIC SYNDROME; GENETIC-CHARACTERIZATION; DIFFERENT SEROPATHOTYPES; O157; INFECTION; NON-O157; STEC; STRAINS; ASSOCIATION; HUMANS; OUTBREAKS; VARIANTS;
D O I
10.1128/JCM.03590-14
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Shiga toxin-producing Escherichia coli (STEC) is an enteropathogen of public health concern because of its ability to cause serious illness and outbreaks. In this prospective study, a diagnostic screening algorithm to categorize STEC infections into risk groups was evaluated. The algorithm consists of prescreening stool specimens with real-time PCR (qPCR) for the presence of stx genes. The qPCR-positive stool samples were cultured in enrichment broth and again screened for stx genes and additional virulence factors (escV, aggR, aat, bfpA) and O serogroups (O26, O103, O104, O111, O121, O145, O157). Also, PCR-guided culture was performed with sorbitol MacConkey agar (SMAC) and CHROMagar STEC medium. The presence of virulence factors and O serogroups was used for presumptive pathotype (PT) categorization in four PT groups. The potential risk for severe disease was categorized from high risk for PT group I to low risk for PT group III, whereas PT group IV consists of unconfirmed stx qPCR-positive samples. In total, 5,022 stool samples of patients with gastrointestinal symptoms were included. The qPCR detected stx genes in 1.8% of samples. Extensive screening for virulence factors and O serogroups was performed on 73 samples. After enrichment, the presence of stx genes was confirmed in 65 samples (89%). By culture on selective media, STEC was isolated in 36% (26/73 samples). Threshold cycle (C-T) values for stx genes were significantly lower after enrichment compared to direct qPCR (P < 0.001). In total, 11 (15%), 19 (26%), 35 (48%), and 8 (11%) samples were categorized into PT groups I, II, III, and IV, respectively. Several virulence factors (stx(2), stx(2a), stx(2f), toxB, eae, efa1, cif, espA, tccP, espP, nleA and/or nleB, tir cluster) were associated with PT groups I and II, while others (stx(1), eaaA, mch cluster, ireA) were associated with PT group III. Furthermore, the number of virulence factors differed between PT groups (analysis of variance, P < 0.0001). In conclusion, a diagnostic algorithm enables fast discrimination of STEC infections associated with a high to moderate risk for severe disease (PT groups I and II) from less-virulent STEC (PT group III).
引用
收藏
页码:1588 / 1598
页数:11
相关论文
共 51 条
[11]   Virulence gene profiling of enterohemorrhagic (EHEC) and enteropathogenic (EPEC) Escherichia coli strains: a basis for molecular risk assessment of typical and atypical EPEC strains [J].
Bugarel, Marie ;
Martin, Annett ;
Fach, Patrick ;
Beutin, Lothar .
BMC MICROBIOLOGY, 2011, 11
[12]   Incidence and Virulence Determinants of Verocytotoxin-Producing Escherichia coli Infections in the Brussels-Capital Region, Belgium, in 2008-2010 [J].
Buvens, Glenn ;
De Gheldre, Yves ;
Dediste, Anne ;
de Moreau, Anne-Isabelle ;
Mascart, Georges ;
Simon, Anne ;
Allemeersch, Daniel ;
Scheutz, Flemming ;
Lauwers, Sabine ;
Pierard, Denis .
JOURNAL OF CLINICAL MICROBIOLOGY, 2012, 50 (04) :1336-1345
[13]   Improved Detection of Five Major Gastrointestinal Pathogens by Use of a Molecular Screening Approach [J].
de Boer, Richard F. ;
Ott, Alewijn ;
Kesztyus, Barbara ;
Kooistra-Smid, Anna M. D. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2010, 48 (11) :4140-4146
[14]   Prevalence, virulence profiles, and clinical significance of Shiga toxin-negative variants of enterohemorrhagic Escherichia coli O157 infection in humans [J].
Friedrich, Alexander W. ;
Zhang, Wenlan ;
Bielaszewska, Martina ;
Mellmann, Alexander ;
Koeck, Robin ;
Fruth, Angelika ;
Tschaepe, Helmut ;
Karch, Helge .
CLINICAL INFECTIOUS DISEASES, 2007, 45 (01) :39-45
[15]   Shiga toxin 1c-producing Escherichia coli strains:: Phenotypic and genetic characterization and association with human disease [J].
Friedrich, AW ;
Borell, J ;
Bielaszewska, M ;
Fruth, A ;
Tschäpe, H ;
Karch, H .
JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (06) :2448-2453
[16]   Escherichia coli harboring shiga toxin 2 gene variants:: frequency and association with clinical symptoms [J].
Friedrich, AW ;
Bielaszewska, M ;
Zhang, WL ;
Pulz, M ;
Kuczius, T ;
Ammon, A ;
Karch, H .
JOURNAL OF INFECTIOUS DISEASES, 2002, 185 (01) :74-84
[17]   Emergence of Escherichia coli encoding Shiga toxin 2f in human Shiga toxin-producing E-coli (STEC) infections in the Netherlands, January 2008 to December 2011 [J].
Friesema, I. ;
van der Zwaluw, K. ;
Schuurman, T. ;
Kooistra-Smid, M. ;
Franz, E. ;
van Duynhoven, Y. ;
van Pelt, W. .
EUROSURVEILLANCE, 2014, 19 (17) :26-32
[18]   Association of virulence genotype with phylogenetic background in comparison to different seropathotypes of Shiga toxin-producing Escherichia coli isolates [J].
Girardeau, JP ;
Dalmasso, A ;
Bertin, Y ;
Ducrot, C ;
Bord, S ;
Livrelli, V ;
Vernozy-Rozand, C ;
Martin, C .
JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (12) :6098-6107
[19]   THE EPIDEMIOLOGY OF INFECTIONS CAUSED BY ESCHERICHIA-COLI O157-H7, OTHER ENTEROHEMORRHAGIC ESCHERICHIA-COLI, AND THE ASSOCIATED HEMOLYTIC UREMIC SYNDROME [J].
GRIFFIN, PM ;
TAUXE, RV .
EPIDEMIOLOGIC REVIEWS, 1991, 13 :60-98
[20]   Shiga toxin-producing Escherichia coli:: An overview [J].
Gyles, C. L. .
JOURNAL OF ANIMAL SCIENCE, 2007, 85 :E45-E62